Robert LeBoyer
Stock Analyst at Noble Financial
(0.04)
# 4,708
Out of 4,978 analysts
428
Total ratings
27.6%
Success rate
-12.8%
Average return
Main Sectors:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GOVX GeoVax Labs | Reiterated: Buy | $10 | $0.4052 | +2,367.92% | 27 | Sep 15, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $12 | $0.9984 | +1,101.92% | 44 | Sep 10, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $10 | $2.67 | +274.53% | 23 | Sep 4, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $50 | $4.78 | +946.03% | 20 | Aug 13, 2026 | |
| NTRB Nutriband | Reiterated: Buy | $15 | $7.03 | +113.37% | 10 | Aug 12, 2026 | |
| NNVC NanoViricides | Reiterated: Buy | $6 | $1.20 | +400.00% | 3 | Aug 11, 2026 | |
| NRSN NeuroSense Therapeutics | Reiterated: Buy | $9 | $6.49 | +38.67% | 8 | Aug 11, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $20 | $6.70 | +198.51% | 11 | Aug 10, 2026 | |
| CVKD Cadrenal Therapeutics | Reiterated: Buy | $45 | $1.08 | +4,066.67% | 17 | Jul 14, 2026 | |
| MAIA MAIA Biotechnology | Reiterated: Buy | $14 | $1.40 | +900.00% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $15.63 | +187.91% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $10 | $1.14 | +777.19% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.35 | +788.89% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.53 | +22.51% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $37 | $11.76 | +214.63% | 30 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.08088 | n/a | 5 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9906 | n/a | 36 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5332 | n/a | 24 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.099 | n/a | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.41 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $1.07 | n/a | 11 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.70 | $0.05 | n/a | 2 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $20 | $2.36 | n/a | 10 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $27 | $0.0001 | n/a | 7 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $4.62 | n/a | 8 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $2.04 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $14 | $1.51 | n/a | 7 | Jan 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.50 | n/a | 2 | Dec 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.6769 | n/a | 6 | Dec 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.00001 | n/a | 5 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.07 | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.2329 | n/a | 8 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.54 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.21 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.11 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $1 | $30.46 | n/a | 2 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9602 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.26 | n/a | 3 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.03 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.47 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1651 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 4 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $54 → $41 | $27.54 | n/a | 2 | Aug 5, 2016 |
GeoVax Labs
Sep 15, 2026
Reiterated: Buy
Price Target: $10
Current: $0.4052
Upside: +2,367.92%
Ocugen
Sep 10, 2026
Reiterated: Buy
Price Target: $12
Current: $0.9984
Upside: +1,101.92%
Eledon Pharmaceuticals
Sep 4, 2026
Reiterated: Buy
Price Target: $10
Current: $2.67
Upside: +274.53%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $4.78
Upside: +946.03%
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $7.03
Upside: +113.37%
NanoViricides
Aug 11, 2026
Reiterated: Buy
Price Target: $6
Current: $1.20
Upside: +400.00%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $9
Current: $6.49
Upside: +38.67%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $6.70
Upside: +198.51%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $1.08
Upside: +4,066.67%
MAIA Biotechnology
Jul 9, 2026
Reiterated: Buy
Price Target: $14
Current: $1.40
Upside: +900.00%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $15.63
Upside: +187.91%
May 27, 2026
Reiterated: Buy
Price Target: $6 → $10
Current: $1.14
Upside: +777.19%
May 22, 2026
Reiterated: Buy
Price Target: $12
Current: $1.35
Upside: +788.89%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $6.53
Upside: +22.51%
Mar 16, 2026
Reiterated: Buy
Price Target: $70 → $37
Current: $11.76
Upside: +214.63%
Jun 27, 2025
Rated: Hold
Price Target: n/a
Current: $0.08088
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.9906
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.5332
Upside: n/a
Jan 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.099
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $5
Current: $3.41
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $8 → $9
Current: $1.07
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.70
Current: $0.05
Upside: n/a
May 14, 2021
Reiterated: Buy
Price Target: $20 → $20
Current: $2.36
Upside: n/a
Feb 9, 2021
Reiterated: Buy
Price Target: $18 → $27
Current: $0.0001
Upside: n/a
Jan 26, 2021
Reiterated: Buy
Price Target: $6 → $15
Current: $4.62
Upside: n/a
Jan 25, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $2.04
Upside: n/a
Jan 24, 2021
Reiterated: Buy
Price Target: $6 → $14
Current: $1.51
Upside: n/a
Dec 28, 2020
Downgraded: Hold
Price Target: n/a
Current: $5.50
Upside: n/a
Dec 24, 2020
Reiterated: Buy
Price Target: $6
Current: $0.6769
Upside: n/a
Nov 12, 2020
Reiterated: Buy
Price Target: $8
Current: $0.00001
Upside: n/a
Oct 5, 2020
Downgraded: Hold
Price Target: n/a
Current: $11.07
Upside: n/a
May 28, 2020
Reiterated: Buy
Price Target: $5
Current: $0.2329
Upside: n/a
Feb 18, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $1.54
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $3.21
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $4.11
Upside: n/a
Apr 10, 2018
Downgraded: Hold
Price Target: $17 → $1
Current: $30.46
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.9602
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $7.26
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $2.03
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.47
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.1651
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 5, 2016
Downgraded: Hold
Price Target: $54 → $41
Current: $27.54
Upside: n/a